We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Withdraws 27 Approved ANDAs Under Consent Decree
Ranbaxy Withdraws 27 Approved ANDAs Under Consent Decree
August 28, 2012
Ranbaxy has withdrawn its approved ANDAs for 27 U.S. drugs to focus on other applications and fixing good manufacturing practice deviations that prompted a consent decree earlier this year.